G Sturfelt

2.5k total citations
21 papers, 1.1k citations indexed

About

G Sturfelt is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, G Sturfelt has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 11 papers in Immunology and 5 papers in Nephrology. Recurrent topics in G Sturfelt's work include Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (5 papers) and Renal Diseases and Glomerulopathies (5 papers). G Sturfelt is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (5 papers) and Renal Diseases and Glomerulopathies (5 papers). G Sturfelt collaborates with scholars based in Sweden, Denmark and Germany. G Sturfelt's co-authors include Ola Nived, Aladdin J Mohammad, Mårten Segelmark, L. Jacobsson, Kerstin Westman, Paul R. Fortin, Charlie H. Goldsmith, Caroline Gordon, Michelle Petri and M L Snaith and has published in prestigious journals such as Kidney International, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

G Sturfelt

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Sturfelt Sweden 12 760 574 225 152 142 21 1.1k
Kyriaki Boki Greece 21 761 1.0× 347 0.6× 273 1.2× 150 1.0× 72 0.5× 54 1.2k
Francesca Bellisai Italy 21 611 0.8× 313 0.5× 200 0.9× 87 0.6× 234 1.6× 62 1.1k
DT Boumpas Greece 14 544 0.7× 383 0.7× 114 0.5× 128 0.8× 262 1.8× 25 1.1k
I-M Gilboe Norway 15 577 0.8× 312 0.5× 67 0.3× 79 0.5× 138 1.0× 17 882
Gabriella Morozzi Italy 23 962 1.3× 492 0.9× 104 0.5× 73 0.5× 189 1.3× 57 1.4k
Sandrine Jousse France 12 387 0.5× 313 0.5× 94 0.4× 67 0.4× 78 0.5× 22 764
Lena Schiffer Germany 19 536 0.7× 692 1.2× 104 0.5× 247 1.6× 191 1.3× 38 1.3k
Joseph Golbus United States 11 543 0.7× 404 0.7× 73 0.3× 118 0.8× 237 1.7× 16 1.0k
Kiyoshi Takasugi Japan 18 461 0.6× 209 0.4× 114 0.5× 107 0.7× 401 2.8× 51 1.0k
Kathleen Maksimowicz‐McKinnon United States 21 885 1.2× 620 1.1× 936 4.2× 305 2.0× 234 1.6× 32 1.7k

Countries citing papers authored by G Sturfelt

Since Specialization
Citations

This map shows the geographic impact of G Sturfelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Sturfelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Sturfelt more than expected).

Fields of papers citing papers by G Sturfelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Sturfelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Sturfelt. The network helps show where G Sturfelt may publish in the future.

Co-authorship network of co-authors of G Sturfelt

This figure shows the co-authorship network connecting the top 25 collaborators of G Sturfelt. A scholar is included among the top collaborators of G Sturfelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Sturfelt. G Sturfelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tydén, Helena, Christian Lood, Andreas Jönsen, et al.. (2013). Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. Lara D. Veeken. 52(11). 2048–2055. 65 indexed citations
3.
Wang, Chao, Annika Ahlford, Gunnel Nordmark, et al.. (2013). Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility. Genes and Immunity. 14(4). 217–222. 28 indexed citations
4.
Petri, Michelle, Caroline Gordon, JT Merrill, et al.. (2011). Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Carolina Digital Repository (University of North Carolina at Chapel Hill). 1 indexed citations
5.
Ekman, Carl Johan, Andreas Jönsen, G Sturfelt, Anders Bengtsson, & Björn Dahlbäck. (2011). Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Lara D. Veeken. 50(6). 1064–1069. 72 indexed citations
6.
Mohammad, Aladdin J, L. Jacobsson, Kerstin Westman, G Sturfelt, & Mårten Segelmark. (2009). Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Lara D. Veeken. 48(12). 1560–1565. 191 indexed citations
7.
Mohammad, Aladdin J, Omran Bakoush, G Sturfelt, & Mårten Segelmark. (2009). The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI). Scandinavian Journal of Rheumatology. 38(4). 268–275. 20 indexed citations
8.
Yu, Xinhua, L Truedsson, O Nived, et al.. (2009). Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus. Lupus. 18(4). 309–312. 24 indexed citations
9.
Gunnarsson, Iva, Elisabet Svenungsson, G Sturfelt, et al.. (2007). A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus. Tissue Antigens. 70(5). 412–414. 7 indexed citations
10.
Fenton, Kristin Andreassen, E. Mortensen, Randi Olsen, et al.. (2007). Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney International. 71(7). 664–672. 152 indexed citations
11.
Bengtsson, AA, G Sturfelt, Birgitta Gullstrand, & Lennart Truedsson. (2004). Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus − an additional mechanism to increased autoantigen load?. Clinical & Experimental Immunology. 135(3). 535–543. 52 indexed citations
12.
Prokunina‐Olsson, Ludmila, Casimiro Castillejo-López, Iva Gunnarsson, et al.. (2000). The PD-1 gene is associated with nephritis in human systemic lupus erythematosus. Arthritis & Rheumatism. 43. 2858. 9 indexed citations
13.
Alarcón‐Riquelme, Marta E., Inger Jonasson, Bo Johanneson, et al.. (1999). Genetic analysis of the contribution of IL10 to systemic lupus erythematosus.. PubMed. 26(10). 2148–52. 30 indexed citations
14.
Jónsson, Helgi, G Sturfelt, Ulla Mårtensson, Lennart Truedsson, & A.G. Sjöholm. (1996). Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.. PubMed. 13(5). 573–80. 17 indexed citations
15.
Saxena, Ramesh, G Sturfelt, Ola Nived, & Jörgen Wieslander. (1994). Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.. Annals of the Rheumatic Diseases. 53(10). 659–665. 7 indexed citations
16.
Jónsson, Helgi, A.G. Sjöholm, Ulla Mårtensson, Anna‐Brita Laurell, & G Sturfelt. (1991). Cl Subcomponent Complexes and C2 Cleavage in Active Systemic Lupus erythematosus. PubMed. 8(1). 1–12. 7 indexed citations
17.
Rydgren, L, G Sturfelt, & Björn Svensson. (1989). Random locomotion and phagocytosis of monocytes in undiluted normal serum and in undiluted SLE serum.. PubMed. 6(4). 355–9. 2 indexed citations
18.
Nived, Ola, et al.. (1987). Anticardiolipin and complement activation: relation to clinical symptoms.. PubMed. 14 Suppl 13. 149–53. 30 indexed citations
19.
Sturfelt, G, et al.. (1983). Impaired monocyte motility in sera from patients with systemic lupus erythematosus.. PubMed. 91(2). 151–8. 1 indexed citations
20.
Svensson, Björn & G Sturfelt. (1980). Monocyte in vitro function in systemic lupus erythematosus (SLE). II. Glass adherence and spreading in presence of SLE-sera.. PubMed. 31. 43–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026